Best Healthcare Stocks To Research - November 20th

UnitedHealth Group logo with Healthcare background
Image from MarketBeat Media, LLC.

Key Points

  • UnitedHealth Group, Eli Lilly, and Johnson & Johnson were identified by MarketBeat’s screener as healthcare stocks with the highest dollar trading volume in recent days.
  • The companies represent different healthcare areas: UnitedHealth runs health-benefits and Optum businesses, Lilly develops pharmaceuticals including diabetes and obesity treatments, and J&J operates Innovative Medicine and MedTech segments.
  • All three shares rose on Friday: UnitedHealth gained $13.77 to $344.25, Lilly rose $2.00 to $1,353.12, and J&J advanced $3.51 to $270.65.
  • Interested in UnitedHealth Group? Here are five stocks we like better.

UnitedHealth Group, Eli Lilly and Company, and Johnson & Johnson are the three Healthcare stocks to watch today, according to MarketBeat's stock screener tool. Healthcare stocks are shares of publicly traded companies that provide healthcare-related products or services, such as pharmaceutical and biotech firms, medical-device makers, hospitals, and health insurers. For investors, these stocks can be affected by factors including drug approvals, clinical-trial results, regulation, and demand for medical care. These companies had the highest dollar trading volume of any Healthcare stocks within the last several days.

UnitedHealth Group (UNH)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Shares of UnitedHealth Group stock traded up $13.77 on Friday, hitting $344.25. 6,281,846 shares of the company's stock were exchanged, compared to its average volume of 7,260,841. The company has a 50-day simple moving average of $389.42 and a 200-day simple moving average of $367.27. UnitedHealth Group has a 1 year low of $255.96 and a 1 year high of $461.62. The company has a debt-to-equity ratio of 0.66, a quick ratio of 0.74 and a current ratio of 0.74. The stock has a market capitalization of $308.46 billion, a PE ratio of 19.65, a PEG ratio of 1.27 and a beta of 0.51.

Read Our Latest Research Report on UNH

Eli Lilly and Company (LLY)

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. The company offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity.

Shares of Eli Lilly and Company stock traded up $2.00 during trading hours on Friday, hitting $1,353.12. The company's stock had a trading volume of 1,388,315 shares, compared to its average volume of 2,950,835. The company has a debt-to-equity ratio of 1.17, a quick ratio of 1.00 and a current ratio of 1.39. The business has a 50 day moving average price of $1,263.45 and a two-hundred day moving average price of $1,117.53. Eli Lilly and Company has a 12-month low of $850.51 and a 12-month high of $1,475.25. The company has a market cap of $1.27 trillion, a PE ratio of 43.87, a PEG ratio of 1.65 and a beta of 0.40.

Read Our Latest Research Report on LLY

Johnson & Johnson (JNJ)

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension.

Johnson & Johnson stock traded up $3.51 during midday trading on Friday, reaching $270.65. 3,749,165 shares of the stock traded hands, compared to its average volume of 7,946,023. The stock's fifty day moving average is $267.43 and its 200-day moving average is $250.79. Johnson & Johnson has a 12 month low of $199.90 and a 12 month high of $290.25. The company has a quick ratio of 0.74, a current ratio of 1.02 and a debt-to-equity ratio of 0.44. The stock has a market cap of $651.55 billion, a P/E ratio of 40.99, a PEG ratio of 2.74 and a beta of 0.22.

Read Our Latest Research Report on JNJ

Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in UnitedHealth Group Right Now?

Before you consider UnitedHealth Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.

While UnitedHealth Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Blue-Chip Stocks to Add To Your Forever Portfolio Cover

A strong long-term portfolio starts with companies that can survive recessions, inflation, changing consumer habits, and shifting market leadership.

This report names seven blue-chip stocks across technology, retail, consumer staples, healthcare, networking, sporting goods, and utilities that offer investors a mix of stability, income, growth, and staying power.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines